Gene panel testing for breast cancer should not be used to confirm syndromic gene associations
AffiliationManchester Centre for Genomic Medicine, Central Manchester University Hospitals NHS Foundation Trust, Manchester
MetadataShow full item record
CitationEvans DG, Howell SJ, Frayling IM, Peltonen J. Gene panel testing for breast cancer should not be used to confirm syndromic gene associations. NPJ Genom Med. 2018;3:32.
JournalNPJ Genomic Medicine
- Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.
- Authors: Couch FJ, Shimelis H, Hu C, Hart SN, Polley EC, Na J, Hallberg E, Moore R, Thomas A, Lilyquist J, Feng B, McFarland R, Pesaran T, Huether R, LaDuca H, Chao EC, Goldgar DE, Dolinsky JS
- Issue date: 2017 Sep 1
- Evaluation of a 27-gene inherited cancer panel across 630 consecutive patients referred for testing in a clinical diagnostic laboratory.
- Authors: Gardner SA, Weymouth KS, Kelly WS, Bogdanova E, Chen W, Lupu D, Suhl J, Zeng Q, Geigenmüller U, Boles D, Okamoto PM, McDowell G, Hayden MA, Nagan N
- Issue date: 2018
- Multi gene panel testing for hereditary breast cancer - is it ready to be used?
- Authors: Catana A, Apostu AP, Antemie RG
- Issue date: 2019 Jul
- A Next Generation Sequencing custom gene panel as first line diagnostic tool for atypical cases of syndromic obesity: Application in a case of Alström syndrome.
- Authors: Maltese PE, Iarossi G, Ziccardi L, Colombo L, Buzzonetti L, Crinò A, Tezzele S, Bertelli M
- Issue date: 2018 Feb
- The Cost-Effectiveness of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer in Norway.
- Authors: Asphaug L, Melberg HO
- Issue date: 2019 Jan-Jun